Publicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (55)

2024

  1. Efficacy and safety and efficacy of bempedoic acid in acute coronary syndrome. Design of the clinical trial ES-BempeDACS

    Revista Espanola de Cardiologia

  2. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

  3. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

2023

  1. Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87

  2. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  3. Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study

    Thrombosis Journal, Vol. 21, Núm. 1

  4. Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction

    Diabetes Research and Clinical Practice, Vol. 203

  5. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

  6. The current clinical practice for management of post-infarction ventricular septal rupture: a European survey

    European Heart Journal Open, Vol. 3, Núm. 5

2022

  1. Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome

    Journal of Clinical Medicine, Vol. 11, Núm. 6

  2. Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211

  3. Optimal surgical timing after post-infarction ventricular septal rupture

    Cardiology Journal, Vol. 29, Núm. 5, pp. 773-781

  4. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2021

  1. Evaluation of optimal medical therapy in acute myocardial infarction patients with prior stroke

    Therapeutic Advances in Chronic Disease, Vol. 12

  2. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  3. In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide spanish database

    Cardiology Journal, Vol. 28, Núm. 4, pp. 589-597

  4. MEESSI-AHF risk score performance to predict multiple post-index event and post-discharge short-term outcomes

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 2, pp. 142-152

  5. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    The Lancet, Vol. 397, Núm. 10270, pp. 199-207

  6. Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  7. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178